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Abstract
Stimulation of rat peritoneal neutrophils with staurosporine (64 nM) induced production of macrophage inflammatory
protein-2 (MIP-2) and phosphorylation of p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated
kinase/MAP kinase (ERK/MAPK). The staurosporine-induced MIP-2 production at 4 h was inhibited by the highly specific
p38 MAPK inhibitor SB 203580 and the MAPK/ERK kinase (MEK-1) inhibitor PD 98059 in a concentration-dependent
manner. By treatment with SB 203580 (1 WM) or PD 98059 (50 WM), the staurosporine-induced increase in the levels of
mRNA for MIP-2 was only partially lowered, although the staurosporine-induced MIP-2 production was completely
inhibited. Consistent with the inhibition by the protein synthesis inhibitor cycloheximide, SB 203580 and PD 98059 inhibited
MIP-2 production at 4 h either when added simultaneously with staurosporine or 2 h after stimulation with staurosporine. In
contrast, the DNA-dependent RNA polymerase inhibitor actinomycin D did not inhibit MIP-2 production at 4 h when it was
added 2 h after staurosporine stimulation. Dot blot analysis demonstrated that treatment with SB 203580 or PD 98059 down-
regulates the stability of MIP-2 mRNA. These results suggested that p38 MAPK and ERK/MAPK pathways are involved in
translation of MIP-2 mRNA to protein and stabilization of MIP-2 mRNA. ß 1999 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Chemokines represent an increasing superfamily of
structurally and functionally related proteins which
play important roles in in£ammation and immune
responses. They are classi¢ed into CC, CXC, CX3C
and C chemokine subfamilies according to whether
the ¢rst two cysteines are separated or adjacent. In
humans, interleukin (IL)-8 is the major CXC chemo-
kine [1]. In rats, cytokine-induced neutrophil chemo-
attractants (CINCs) [2] including CINC-1, CINC-2K,
CINC-2L and macrophage in£ammatory protein-2
(MIP-2 also known as CINC-3) [3^8] are important
chemoattractants for neutrophils.
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Previously, we found [9] that the production of
MIP-2 by leukocytes in¢ltrating the pouch £uid in
the air pouch-type allergic in£ammation model in
rats is inhibited by the protein kinase C (PKC) in-
hibitor H-7, and the tyrosine kinase inhibitor geni-
stein, but not by the cyclic adenosine 3P,5P-mono-
phosphate (cyclic AMP)-dependent protein kinase
inhibitor H-89. Furthermore, we found [10] that
staurosporine, generally used as a non-speci¢c pro-
tein kinase inhibitor, stimulates MIP-2 production in
rat peritoneal neutrophils, and the staurosporine-in-
duced MIP-2 production is inhibited by the PKC
inhibitors H-7 and calphostin C, and the tyrosine
kinase inhibitor genistein, suggesting that staurospor-
ine activates some PKC isozymes and tyrosine kinase
which lead to MIP-2 production. Recently, it has
been reported that p38 mitogen-activated protein
kinase (MAPK) and extracellular signal-regulated
kinase (ERK)/MAPK cascade pathways are involved
in the regulation of IL-6 and IL-8 production [11^
13]. The purpose of the present study was to clarify
whether MAPK signaling pathways are involved in
the staurosporine-induced MIP-2 production in rat
peritoneal neutrophils.
2. Materials and methods
2.1. Reagents
The drugs used were staurosporine (Kyowa Me-
dex, Tokyo, Japan), PD 98059 (Daiichi Pure Chem-
icals, Tokyo, Japan), SB 203580 (Smithkline Beech-
am Pharmaceuticals, King of Prussia, PA, USA),
actinomycin D (Wako Pure Chemicals, Osaka, Ja-
pan), and cycloheximide (Sigma, St. Louis, MO,
USA). They were dissolved in dimethylsulfoxide,
and an aliquot of each solution was added to me-
dium. The ¢nal concentration of the vehicle in me-
dium was adjusted to 0.1% (v/v). The control me-
dium contained the same amount of the vehicle.
2.2. Preparation of rat peritoneal neutrophils
Male Sprague-Dawley strain rats, speci¢c patho-
gen-free (Charles River Japan, Kanagawa, Japan)
were used. The rats were treated in accordance
with procedures approved by the Animal Ethics
Committee of the Faculty of Pharmaceutical Scien-
ces, Tohoku University, Sendai, Japan. Rat perito-
neal neutrophils were harvested 16 h after intraper-
itoneal injection of 40 ml of Ca2-free Krebs-Ringer
solution containing 1% casein (casein from milk, vi-
tamin-free, Wako Pure Chemicals) which had been
sterilized by autoclaving at 120‡C for 15 min [10].
The peritoneal cells were washed twice with Ca2-
free phosphate-bu¡ered saline (PBS, pH 7.4) and ¢-
nally suspended in RPMI 1640 medium (Nissui
Seiyaku, Tokyo, Japan) containing 0.25% (w/v) bo-
vine serum albumin (BSA, Sigma) at 2U107 cells/ml.
The purity of neutrophils was more than 97% as
assessed by May Gru«nwald-Giemsa staining.
2.3. Cell culture
Rat peritoneal neutrophils (1U107 cells) were in-
cubated in 1 ml of RPMI 1640 medium containing
0.25% BSA (w/v) and the indicated concentrations of
drugs at 37‡C for 4 h. The cells were then centrifuged
at 1500Ug and 4‡C for 5 min. The supernatant ob-
tained was diluted with RPMI 1640 medium contain-
ing 0.25% (w/v) BSA, and used for the measurement
of neutrophil chemotactic activity and for the deter-
mination of MIP-2. After treatment with drugs, the
viability of the neutrophils was examined by the abil-
ity of mitochondrial succinate dehydrogenase to
cleave 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tet-
razolium bromide (MTT) to the blue compound for-
mazan [14], and no signi¢cant changes in viability of
the cells was observed.
2.4. Western blot analysis of p38 MAPK and
ERK/MAPK phosphorylation
After stimulation of neutrophils (5U106 cells) with
staurosporine (64 nM) at 37‡C for 1, 3, 5, 10, 15, 30
and 60 min, the cells were lysed in 100 Wl of ice-cold
lysis bu¡er (20 mM HEPES, pH 7.3, 1% (v/v) Triton
X-100, 1 mM EDTA, 50 mM NaF, 2.5 mM p-nitro-
phenylphosphate, 1 mM Na3VO4, 10 Wg/ml leupeptin
and 10% (v/v) glycerol). Proteins in the cell lysate
were resolved by 8% sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) and
transferred onto nitrocellulose membranes (Schleich-
er and Schuell, Dassel, Germany). The membranes
were blocked in Block Ace (Dainippon Pharmaceut-
BBAMCR 14473 20-5-99
Y.-Q. Xiao et al. / Biochimica et Biophysica Acta 1450 (1999) 155^163156
ical, Osaka, Japan) at room temperature for 1 h and
then incubated overnight at 4‡C with phospho-spe-
ci¢c p38 MAPK (Thr180/Tyr182) antibody or phos-
pho-p44/42 MAPK (Thr202/Tyr204) antibody (New
England Biolabs, Beverly, MA, USA), which was
diluted 1/1000 in 10 mM Tris-HCl, pH 8.0, 150
mM NaCl, 0.1% (v/v) Tween 20 (TBST) containing
1% BSA. After extensive washes, the membranes
were incubated with 1/2000 diluted biotinylated
anti-rabbit IgG (Vector Laboratories, Burlingame,
CA, USA) for 1 h at room temperature. After three
washes in TBST, the membranes were treated with
enhanced chemiluminescence reagents (ECL, Amer-
sham Life Science, Buckinghamshire, UK), and the
phosphorylated p38 MAPK and ERK/MAPK were
detected by autoradiography with Kodak Scienti¢c
Imaging Films (Eastman Kodak, Rochester, NY,
USA).
To con¢rm that equal amounts of protein were
loaded in each lane, the membranes were incubated
in stripping bu¡er (62.5 mM Tris-HCl, pH 6.7, 2%
SDS and 100 mM L-mercaptoethanol) at 50‡C for 30
min to remove the complex of the primary antibody
and the secondary antibody. The blots were blocked
in Block Ace, and reprobed with p38 (C-20) (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) or anti-
rat MAPK R2 (Upstate Biotechnology, Lake Placid,
NY, USA), followed with alkaline phosphatase-con-
jugated anti-rabbit IgG (Kirkegaard and Perry Lab-
oratories, Gaithersburg, MD, USA). Proteins were
visualized using a nitroblue tetrazolium/5-bromo-4-
chloro-3-indolylphosphate system (Promega, Madi-
son, WI, USA).
2.5. Measurement of neutrophil chemotactic activity
The chemotactic activity of MIP-2 in the super-
natant fraction of the conditioned medium was de-
termined using modi¢ed Boyden chambers and ex-
pressed as migration index according to the
procedure described previously [15].
2.6. Determination of MIP-2 in the conditioned
medium by ELISA
Concentrations of MIP-2 in the conditioned me-
dium were measured by the enzyme-linked immuno-
sorbent assay (ELISA) system which we have devel-
oped. Brie£y, we produced GST-fusion rat MIP-2
protein and prepared its polyclonal antibody using
rabbits as described previously [8]. The enzyme-la-
beled antibody was produced by conjugation of per-
oxidase (Toyobo, Tokyo, Japan) to anti-MIP-2 poly-
clonal antibody. 3,3P,5,5P-Tetramethylbenzidine
(TMBZ) (Dojindo Laboratories, Kumamoto, Japan)
was used as a substrate for peroxidase. The detection
range for rat MIP-2 is between 6.25 and 400 pg/ml
without cross-reaction with CINC-1, CINC-2K and
CINC-2L.
2.7. Northern blot and dot blot analysis of MIP-2
mRNA
Rat peritoneal neutrophils (8U107 cells) were in-
cubated at 37‡C for the periods indicated in 8 ml of
RPMI 1640 medium containing 0.25% (w/v) BSA in
the presence or absence of drugs. Total RNA was
then prepared from neutrophils by acid guanidi-
nium-phenol-chloroform extraction [16]. For North-
ern blotting, 15 Wg of total RNA from each sample
was loaded and separated on a 1% agarose gel con-
taining 1.7% formaldehyde and blotted onto a Hy-
bond-N membrane (Amersham Life Science). For
dot blotting, 10 Wg of total RNA was denatured in
1USSC (0.15 M NaCl, 15 mM sodium citrate, pH
7.0) containing 50% formamide and 7% formalde-
hyde at 68‡C for 15 min, and blotted onto a Hy-
bond-N membrane using a dot blot apparatus
(ATTO, Tokyo, Japan). Probes for MIP-2 cDNA
and L-actin cDNA were labeled with [K-32P]dCTP
(3000 Ci/mmol) (NEN Life Science Products, Bos-
ton, MA, USA) using a Ready-To-Go DNA labeling
kit (Pharmacia Biotech, USA), and chromato-
graphed through G-50 Sephadex columns (Boeh-
ringer Mannheim, Indianapolis, IN, USA). The blots
were prehybridized for 3^6 h and then hybridized for
16^18 h at 42‡C in 5USSPE bu¡er (0.75 M NaCl, 50
mM NaH2PO4WH2O, 5 mM EDTA, pH 7.4) contain-
ing 10UDenhardt’s solution, 50% formamide, 2%
SDS, and 100 Wg/ml freshly denatured, sheared sal-
mon sperm DNA (Wako Pure Chemicals). After hy-
bridization, the blots were rinsed three times at room
temperature for 15 min in 2USSC containing 0.05%
SDS, then washed three times at 55‡C for 40 min
each in 0.1USSC containing 0.1% SDS. The mem-
brane was exposed to Kodak Scienti¢c Imaging
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Films (Eastman Kodak) at 380‡C. For rehybridiza-
tion, the hybridized probe was stripped from the blot
by incubating the blot in sterile H2O containing 0.5%
SDS at 90^100‡C for 10 min.
2.8. Statistical analysis
The results are presented as means þ S.E.M. from
at least four samples. Comparisons were performed
by Student’s unpaired t-test.
3. Results
3.1. Stimulation of MIP-2 production by
staurosporine
Concentrations of MIP-2 in the conditioned me-
dium of the staurosporine-stimulated neutrophils was
determined by ELISA. As shown in Fig. 1A, MIP-2
concentrations in the conditioned medium in the ab-
sence of staurosporine were negligible, but were in-
creased time-dependently in the presence of 64 nM of
staurosporine. Signi¢cant increase in MIP-2 produc-
tion at 4 h was observed at 6.4^210 nM of stauro-
sporine in a concentration-dependent manner (data
not shown). Northern blot analysis demonstrated
that the accumulation of MIP-2 mRNA at 4 h in
non-stimulated neutrophils was very low. Following
incubation with staurosporine (64 nM), the MIP-2
mRNA level increased rapidly reaching a maximum
at 3 h and remained unchanged at 4 h (Fig. 1B).
3.2. E¡ects of the p38 MAPK inhibitor SB 203580
and the MEK-1 inhibitor PD 98059 on the
staurosporine-induced MIP-2 production
We then determined whether p38 MAPK and
ERK/MAPK are involved in the staurosporine-
stimulated MIP-2 production. Stimulation of rat
peritoneal neutrophils with staurosporine (64 nM)
activated p38 MAPK and ERK/MAPK, as revealed
by increased phosphorylation (Fig. 2). The phos-
phorylation of p38 MAPK was observed at 5 min,
reached a maximum at 10 min and then declined at
60 min (Fig. 2A). The phosphorylation of ERK/
MAPK by staurosporine was detectable at 5 min
and increased with time till 60 min (Fig. 2B). When
neutrophils were incubated with staurosporine (64
nM) at 37‡C for 4 h, the neutrophil chemotactic
activity in the conditioned medium increased signi¢-
cantly. The staurosporine-induced increase in neutro-
phil chemotactic activity in the conditioned medium
was lowered by the p38 MAPK inhibitor SB 203580
and the MEK-1 inhibitor PD 98059 in a concentra-
tion-dependent manner (Fig. 3A,B). Consistent with
the results obtained by chemotaxis determination
(Fig. 3A,B), stimulation of neutrophils with stauro-
sporine (64 nM) markedly increased MIP-2 produc-
tion at 4 h (Fig. 3C,D). The staurosporine-induced
MIP-2 production was inhibited by SB 203580 and
Fig. 1. Time changes in the production of MIP-2 protein and
the accumulation of MIP-2 mRNA in staurosporine-stimulated
neutrophils. (A) Rat peritoneal neutrophils (1U107 cells) were
incubated at 37‡C for the periods indicated in 1 ml of medium
in the presence or absence of staurosporine (SS, 64 nM). Con-
centrations of MIP-2 in the conditioned medium were deter-
mined by ELISA. Values are the means þ S.E.M. from four
samples. The results were con¢rmed by three separate experi-
ments. (B) Rat peritoneal neutrophils (8U107 cells) were incu-
bated at 37‡C for the periods indicated in 8 ml of medium in
the presence of staurosporine (64 nM). Northern blot analysis
for each MIP-2 mRNA and L-actin mRNA was performed us-
ing 15 Wg of total RNA extracted from neutrophils as described
in Section 2.4.
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PD 98059 in a concentration-dependent manner, and
almost complete inhibition was obtained with 1 WM
SB 203580 and 50 WM PD 98059 (Fig. 3C,D).
3.3. Involvement of p38 MAPK and ERK/MAPK in
the regulation of MIP-2 protein synthesis
We then examined the e¡ects of SB 203580 and
PD 98059 on MIP-2 mRNA accumulation at 2 h
after staurosporine stimulation. Although stauro-
sporine-induced production of MIP-2 protein at 4 h
was almost completely inhibited by 1 WM SB 203580
or 50 WM PD 98059 (Fig. 3C,D), MIP-2 mRNA
accumulation was only partially inhibited (Fig. 4A).
As positive and negative controls, we examined the
e¡ects of actinomycin D and cycloheximide, which
inhibit transcription and translation, respectively. By
treatment with actinomycin D (8 WM), staurospor-
ine-induced accumulation of MIP-2 mRNA at 2 h
was almost completely abolished, but treatment
with cycloheximide (3.6 WM) did not a¡ect the stau-
rosporine-induced increase in MIP-2 mRNA levels at
2 h (Fig. 4A). These ¢ndings suggested that the in-
hibition of staurosporine-induced MIP-2 production
by the inhibitors of p38 MAPK and ERK/MAPK is
expressed at the post-transcriptional level. To further
determine whether p38 MAPK and ERK/MAPK are
key mediators of the stimulation of MIP-2 protein
synthesis by staurosporine, SB 203580 (0.1 WM) or
PD 98059 (10 WM) was added simultaneously with
staurosporine, or 2 h after staurosporine (64 nM)
stimulation, and the levels of MIP-2 production 4 h
after staurosporine stimulation were examined.
Although levels of MIP-2 mRNA were strongly ele-
vated 2 h after stimulation by staurosporine (64 nM)
(Figs. 1B and 4A), only a small amount of MIP-2
protein was synthesized at 2 h (Fig. 1A). Addition of
SB 203580 (0.1 WM) or PD 98059 (10 WM) 2 h after
stimulation with staurosporine inhibited MIP-2 pro-
duction at 4 h, and the inhibitory activity was almost
the same as that when the inhibitors were added
simultaneously with staurosporine (Fig. 4B). Almost
the same inhibition of MIP-2 production at 4 h was
observed when cycloheximide (0.108 WM) was added
2 h after stimulation or simultaneously with stauro-
sporine (Fig. 4B). In contrast, addition of actinomy-
cin D (0.8 WM) 2 h after stimulation with staurospor-
ine did not inhibit MIP-2 production at 4 h.
However, addition of actinomycin D (0.8 WM) to-
gether with SB 203580 (0.1 WM) or PD 98059 (10
WM) 2 h after staurosporine stimulation inhibited
MIP-2 production at 4 h (Fig. 4B). These ¢ndings
suggested that p38 MAPK and ERK/MAPK are in-
volved in the regulation of MIP-2 protein synthesis
at the post-transcriptional level.
3.4. E¡ects of the p38 MAPK inhibitor SB 203580
and the MEK-1 inhibitor PD 98059 on the
stability of MIP-2 mRNA
We next examined whether SB 203580 and PD
98059 a¡ect the stability of MIP-2 mRNA. Because
Northern blot analysis demonstrated each speci¢c
band for MIP-2 and L-actin (Figs. 1B and 4A), we
Fig. 2. Activation of p38 MAPK and ERK/MAPK by stauro-
sporine in rat peritoneal neutrophils. (A) Protein phosphoryla-
tion of p38 MAPK. Rat peritoneal neutrophils (5U106 cells)
were stimulated at 37‡C for the periods indicated in 0.5 ml of
medium in the presence of staurosporine (64 nM). Proteins in
the cell lysate were separated on 8% SDS-PAGE and trans-
ferred onto a nitrocellulose membrane. Western blot was per-
formed using phospho-p38 MAPK (Thr180/Tyr182) antibody
(upper panel), and the sample was reprobed with p38 (C-20)
antibody (lower panel). (B) Protein phosphorylation of ERK/
MAPK. The same samples as described above were subjected
to Western blot analysis using phospho-p44/42 MAPK antibody
(upper panel), and reprobed with anti-rat MAPK R2. The re-
sults shown are representative of three separate experiments.
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performed dot blot analysis in subsequent experi-
ments. Neutrophils were incubated for 2 h in me-
dium containing staurosporine (64 nM) in the pres-
ence or absence of SB 203580 (1 WM) or PD 98059
(50 WM). Actinomycin D (8 WM) was then added and
the cells were further incubated for 1, 2 and 3 h. As
shown in Fig. 5A, levels of L-actin mRNA were not
a¡ected markedly by SB 203580 (1 WM) or PD 98059
(50 WM). However, levels of MIP-2 mRNA decreased
time-dependently in the presence of SB 203580 (1
WM) or PD 98059 (50 WM) (Fig. 5B). These ¢ndings
suggested that the decrease in the levels of MIP-2
mRNA by SB 203580 (1 WM) and PD 98059 (50
WM) (Fig. 4) is partly due to the decrease in the
stability of MIP-2 mRNA. Therefore, it was also
suggested that p38 MAPK and ERK/MAPK pro-
mote the stabilization of the staurosporine-induced
MIP-2 mRNA in neutrophils.
4. Discussion
Staurosporine was originally considered to be a
potent non-selective inhibitor of PKC [17]. It is re-
ported that staurosporine promotes neurite out-
growth by speci¢c activation of JNK isoform in
PC-12 cells [18]. We have reported that staurosporine
induces MIP-2 production in rat peritoneal neutro-
phils with a maximal e¡ect at 64 nM, and the staur-
osporine-induced MIP-2 production is inhibited by
the inhibitors of PKC and tyrosine kinase [10]. In
the present work, we have found that staurosporine
causes phosphorylation of p38 MAPK and ERK/
MAPK in rat neutrophils (Fig. 2). To evaluate the
biologic signi¢cance of the activation of p38 MAPK
and ERK/MAPK by staurosporine, we examined the
e¡ects of SB 203580, a highly speci¢c inhibitor of
p38 MAPK, and PD 98059, a speci¢c inhibitor of
Fig. 3. E¡ects of SB 203580 and PD 98059 on staurosporine-induced MIP-2 production by neutrophils. Rat peritoneal neutrophils
(1U107 cells) were incubated at 37‡C for 4 h in 1 ml of medium in the presence of staurosporine (SS, 64 nM) and the indicated con-
centrations of SB 203580 (A,C) or PD 98059 (B,D). Neutrophil chemotactic activity expressed as migration index in the conditioned
medium was determined after 10-fold dilution (A,B). Chemotaxis induced by 10 nM platelet-activating factor is expressed as 100%.
Concentrations of MIP-2 were determined by ELISA (C,D). Values are the means þ S.E.M. from four samples. Statistical signi¢cance:
***P6 0.001 vs. corresponding control. The results were con¢rmed by three separate experiments.
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MEK-1, on staurosporine-induced MIP-2 produc-
tion. Incubation of neutrophils with staurosporine
(64 nM) in the presence of 1 WM SB 203580 or 50
WM PD 98059 almost completely inhibited MIP-2
production (Fig. 3). Hobbie et al. [11] reported that
SB 203580 speci¢cally inhibits p38 MAPK with an
IC50 of 0.6 WM. Furthermore, maximal inhibition by
SB 203580 of tumor necrosis factor-K (TNF-K)-in-
duced p38 MAPK activation and IL-8 production
was observed at a concentration of 0.15 WM in hu-
man neutrophils [13]. In our previous studies, MIP-2-
induced phosphorylation of ERK/MAPK in rat neu-
trophils was completely inhibited by PD 98059 at 50
WM [19]. Taken together, the present ¢ndings sug-
gested that p38 MAPK and ERK/MAPK play key
roles in the staurosporine-induced MIP-2 produc-
tion.
Fig. 4. E¡ects of SB 203580 and PD 98059 on MIP-2 produc-
tion in neutrophils stimulated with staurosporine. (A) Rat peri-
toneal neutrophils (8U107 cells) were incubated at 37‡C for 2 h
in 8 ml of medium containing staurosporine (SS, 64 nM) alone
or in combination with SB 203580 (SB, 1 WM), PD 98059 (PD,
50 WM), cycloheximide (CHI, 3.6 WM), or actinomycin D (AcD,
8 WM). Total RNA (15 Wg) was extracted and subjected to
Northern blot analysis. Similar results were obtained in three
separate experiments. (B) Rat peritoneal neutrophils (1U107
cells) were incubated at 37‡C for 2 h in 1 ml of medium con-
taining staurosporine (SS, 64 nM), and further incubated for 2 h
in the presence of staurosporine (SS, 64 nM) with SB 203580
(SB, 0.1 WM), PD 98059 (PD, 10 WM), cycloheximide (CHI,
0.108 WM) or actinomycin D (AcD, 0.8 WM). For comparison,
each set of neutrophils (1U107 cells) was incubated at 37‡C for
4 h in 1 ml of medium containing staurosporine (SS, 64 nM)
and each drug (closed bar). Concentrations of MIP-2 in the
conditioned medium were determined by ELISA. Values are the
means þ S.E.M. from four samples. Statistical signi¢cance:
**P6 0.01, ***P6 0.001 vs. SS 2h+AcD. The results were con-
¢rmed by three separate experiments.
Fig. 5. E¡ects of SB 203580 and PD 98059 on the stability of
MIP-2 mRNA in staurosporine-stimulated neutrophils. Rat
peritoneal neutrophils (8U107 cells) were incubated at 37‡C for
2 h in 8 ml of medium containing 64 nM of staurosporine in
the presence and absence of SB 203580 (1 WM) or PD 98059
(50 WM). Actinomycin D (8 WM) was then added to the cul-
tures, and total RNA was extracted at 0, 1, 2 and 3 h after in-
cubation. Dot blot was performed using 10 Wg of extracted
RNA and L-actin probe (A) or MIP-2 probe (B). After densito-
metric scanning, levels of mRNA for L-actin and MIP-2 at
time 0 after addition of actinomycin D were expressed as 100%,
respectively. The results shown are representative of three sepa-
rate experiments.
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In human neutrophils, p38 MAPK activation is
required for IL-8 production stimulated by granulo-
cyte-macrophage colony-stimulating factor (GM-
CSF), lipopolysaccharide (LPS) or TNF-K [13]. It
is also demonstrated that p38 MAPK- and ERK/
MAPK-mediated activation of NF-UB and AP-1 is
involved in Salmonella typhimurium-induced IL-8
production [11]. Recently, it has been reported that
the p38 MAPK pathway is necessary for transcrip-
tional activation of the IL-6 promoter [12]. However,
we found that the inhibition of p38 MAPK and
ERK/MAPK only partially lowered the levels of
staurosporine-induced increase in MIP-2 mRNA
(Fig. 4A). In spite of the complete inhibition of
MIP-2 protein production by the p38 MAPK inhib-
itor SB 203580 (1 WM) or the MEK-1 inhibitor PD
98059 (50 WM), the levels of MIP-2 mRNA were not
completely lowered by SB 203580 (1 WM) or PD
98059 (50 WM). These ¢ndings suggest that the
post-transcriptional regulation of MIP-2 gene is in-
volved in the staurosporine-induced MIP-2 produc-
tion. As reported by Lee et al. [20], p38 MAPK is
critical for the production of IL-1 and TNF-K. In
addition, in insulin-stimulated murine 3T3-L1 adipo-
cytes, when PHAS-1, an initiation factor 4E (eIF-4E)
binding protein, is phosphorylated by ERK2, eIF-4E
is released and participates in the initiation of trans-
lation [21].
As shown in Fig. 4B, almost the same inhibition of
MIP-2 production at 4 h was obtained when SB
203580 (0.1 WM) or PD 98059 (10 WM) was added
2 h after staurosporine (64 nM) stimulation or when
these drugs were added simultaneously with stauro-
sporine. The protein synthesis inhibitor cyclohexi-
mide (0.108 WM) also showed no di¡erence in the
inhibition of MIP-2 production at 4 h when cyclo-
heximide was added simultaneously with staurospor-
ine or 2 h after staurosporine stimulation (Fig. 4B).
In contrast, addition of actinomycin D (0.8 WM), an
inhibitor of DNA-dependent RNA polymerase, 2 h
after staurosporine (64 nM) stimulation failed to in-
hibit MIP-2 production at 4 h. These ¢ndings indi-
cated that MIP-2 mRNA accumulated during the
¢rst 2 h after staurosporine stimulation (Figs. 1B
and 4A) participates in MIP-2 protein production
during the next 2 h, and p38 MAPK and ERK/
MAPK are required for MIP-2 protein production
at the post-transcription level.
The levels of MIP-2 mRNA was decreased parti-
ally by SB 203580 or PD 98059 (Fig. 4A). But this
might be due to the decrease in the stabilization of
MIP-2 mRNA, because the MIP-2 mRNA levels
were decreased much faster in the presence of SB
203580 (1 WM) or PD 98059 (50 WM) than on stim-
ulation with staurosporine (64 nM) alone after the
transcription was disrupted by actinomycin D (8
WM) (Fig. 5). It is reported that the AUUUA se-
quence in the 3P-untranslated region is involved in
the modulation of mRNA stability [22]. mRNAs of
many cytokines, including, but not limited to GM-
CSF, TNF-K, interferon-Q, IL-1, IL-2, IL-3, IL-8,
CINC-1 and MIP-2, contain multiple AUUUA mo-
tifs [22^24]. Because the c-Jun NH2-terminal kinase
(JNK) pathway is involved in the stabilization of IL-
2 mRNA through the 3P-untranslated region [23], it
remains to be clari¢ed whether the stabilization of
MIP-2 mRNA by p38 MAPK and ERK/MAPK
pathways is also through the 3P-untranslated region.
As shown in this paper, staurosporine activates
MAPK and ERK/MAPK and induces MIP-2 pro-
duction in rat peritoneal macrophages as physiologic
in£ammatory stimuli including TNF-K, GM-CSF,
and LPS stimulate IL-8 production in human neu-
trophils [13]. Therefore, the staurosporine-induced
MIP-2 expression system in cell culture might be
useful for the screening of inhibitors of chemokine
production.
In summary, we ¢rst demonstrated that p38
MAPK and ERK/MAPK signaling pathways are in-
volved in the regulation of staurosporine-induced
MIP-2 production in rat peritoneal neutrophils at
the level of post-transcription; they stimulate trans-
lation of MIP-2 mRNA and stabilize its mRNA.
Further investigation is necessary to clarify whether
inhibition of p38 MAPK and ERK/MAPK is useful
for the suppression of chemokine production by neu-
trophils activated by physiologic in£ammatory stim-
uli.
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